Series Vol. 6 , 03 August 2023
* Author to whom correspondence should be addressed.
The discovery of dihydrolucilactaene as a secondary metabolite in fungus Fusarium sp. RK97-94 showed a 100-fold increase in potency in antimalarial activity compared with its analogue—lucilactaene. Although dihydrolucilactaene shows a high level of antimalarial activity and had been shown to be a promising drug lead candidate for malaria treatment due to its highly selective cytotoxicity towards malaria-causing pathogens and negligible cytotoxicity towards other cells at lower concentrations, its complete biosynthesis pathway in Fusarium sp. RK97-94 is still to be determined, making mass production of the molecule via biological means less than desirable. In this work, we propose a complete chemical synthesis route for dihydrolucilactaene via a series of reactions involving commercially available reagents for the potential industrial application and mass production of dihydrolucilactaene.
antimalarial activity, cyclic amide, dihydrolucilactaene, lucilactaene, synthetic pathway
1. Shibeshi, M. A., Kifle, Z. D., & Atnafie, S. A. (2020). <p>Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery</p> Infection and Drug Resistance, Volume 13, 4047–4060. https://doi.org/10.2147/idr.s279433
2. Tse, E. G., Korsik, M., & Todd, M. H. (2019). The past, present and future of anti-malarial medicines. Malaria Journal, 18(1). https://doi.org/10.1186/s12936-019-2724-z
3. Rosenthal, P. J. (2003). Antimalarial drug discovery: old and new approaches. The Journal of Experimental Biology, 206(21), 3735–3744. https://doi.org/10.1242/jeb.00589
4. Abdelhakim, I. A., Mahmud, F. B., Motoyama, T., Futamura, Y., Takahashi, S., & Osada, H. (2021). Dihydrolucilactaene, a Potent Antimalarial Compound from Fusarium sp. RK97-94. Journal of Natural Products, 85(1), 63–69. https://doi.org/10.1021/acs.jnatprod.1c00677
5. Kato, S., Motoyama, T., Futamura, Y., Uramoto, M., Nogawa, T., Hayashi, T., Hirota, H., Tanaka, A., Takahashi-Ando, N., Kamakura, T., & Osada, H. (2020). Biosynthetic gene cluster identification and biological activity of lucilactaene from Fusarium sp. RK97-94. Bioscience, Biotechnology, and Biochemistry, 84(6), 1303–1307. https://doi.org/10.1080/09168451.2020.1725419
6. Kakeya, H., Kageyama, S., Nie, L., Onose, R., Okada, G., Beppu, T., Norbury, C. C., & Osada, H. (2001). Lucilactaene, a New Cell Cycle Inhibitor in p53-Transfected Cancer Cells, Produced by a Fusarium sp. The Journal of Antibiotics, 54(10), 850–854. https://doi.org/10.7164/antibiotics.54.850
7. P. (n.d.). 2,3-Dihydroxypropanal; methane. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/118588631
8. Heterocyclic Chemistry. (n.d.). https://www2.chemistry.msu.edu/faculty/reusch/virttxtjml/heterocy.htm
9. Introduction to polyenes. (n.d.). https://etd.ohiolink.edu/apexprod/rws_etd/send_file/send?accession=osu1206036742&disposition=inline
10. LibreTexts. C−C cross-coupling reactions. https://chem.libretexts.org/Bookshelves/Inorganic_Chemistry/Map%3A_Inorganic_Chemistry_%28Housecroft%29/25%3A_Catalysis_and_some_industrial_processes/25.05%3A_Homogeneous_Catalysis_-_Industrial_Applications/25.5F%3A_CC_cross-coupling_reactions
11. S. (2018, September 23). Silyl Protective Groups. Chem-Station Int. Ed. https://en.chem-station.com/reactions-2/2014/03/silyl-protective-groups.html
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.